NCT07103928

Brief Summary

Assisted partner notification (APN) is a voluntary and confidential process that utilizes specially-trained health workers to encourage and assist people diagnosed with HIV to inform their sex and drug use partners about possible shared exposure to HIV. With APN, partners who have come in contact with HIV are notified about exposure and given information to protect themselves from contracting HIV in the future or to begin treatment, if needed. This study compares two types of HIV partner notification. Incarcerated men with HIV will be recruited as "index participants". Participants in both groups will be encouraged to notify sex and needle-sharing partners with whom they may have shared an HIV exposure before incarceration. All participants have the option to self-notify partners during a prison visitation or telephone call. In addition, participants randomized to an APN Choice group also can opt for anonymous notification by specially-trained APN notifiers that includes contact tracing if needed. As outcomes, we will compare the number of partners in each condition who are notified, HIV tested, diagnosed, and linked to HIV treatment. The study will show if prison-based APN is successful in reaching partners for HIV testing.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
216

participants targeted

Target at P50-P75 for not_applicable hiv

Timeline
28mo left

Started Jun 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jun 2026Dec 2028

First Submitted

Initial submission to the registry

July 29, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 5, 2025

Completed
10 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

July 9, 2026

Status Verified

July 1, 2025

Enrollment Period

2.5 years

First QC Date

July 29, 2025

Last Update Submit

July 7, 2026

Conditions

Keywords

HIVpartner notificationcontact tracingsexually transmitted infectionsprisonsInjection drug use

Outcome Measures

Primary Outcomes (1)

  • HIV Testing

    Number of partners who complete HIV testing

    6 weeks after randomization

Secondary Outcomes (5)

  • HIV Notification

    6 weeks post-randomization

  • First HIV Test

    6 weeks post-randomization

  • HIV Diagnosis

    6 weeks post-randomization

  • ART Linkage

    6 weeks post-randomization

  • ART Initiation

    6 weeks post-randomization

Study Arms (2)

Impart Choice of APN or Self-Tell Per Partner

EXPERIMENTAL

Participants are assisted to identify partners whom they wish to notify and coached in how to tell their at-risk partners by the end of 6 weeks. Participants may choose per partner between sell-tell notification or having an Impart HIV-trained nurse and community outreach healthcare provider work as a team to locate, notify, and offer HIV testing to their partners.

Behavioral: Impart Assisted Partner NotificationBehavioral: Self-Tell Notification

Self-Tell Notification Only Standard of Care Condition

ACTIVE COMPARATOR

Participants are assisted to identify partners whom they wish to notify and coached in how to tell their at-risk partners by the end of 6 weeks. Participants may choose to tell their partner(s) by telephone, mail, or in-person during visitation at the jail/prison facility. They also may elect to have an Impart counselor present during in-person telling or by telephone to answer any clinical questions that the partner might have.

Behavioral: Self-Tell Notification

Interventions

Participants randomized to the Impart arm may choose per partner either a) sell-tell notification or b) having an Impart-trained APN notifier team locate, notify, and offer HIV testing to their partners without revealing the identity of who had named them. Impart notifiers initially contact named partners by telephone and identify themselves as health service providers with important information about the partner's health that needs to be shared in person. Partners who agree to meet are asked to choose a location. Notification by telephone is only delivered as a last resort when circumstances prevent in-person notification or a partner insists on learning the reason for the telephone call. Once contact is made at a private location, partners will be advised of their possible shared exposure to HIV. APN notifiers never reveal participant names or identifying information during this meeting. All notified partners are offered immediate HIV testing and treatment referral, if HIV-positive.

Also known as: HIV partner notification, Provider-assisted partner notification
Impart Choice of APN or Self-Tell Per Partner

Participants who wish to self-notify one or more partners are coached to do so either in person or by telephone. APN counselors confirm the names of partners for whom participants provide contact information before giving the phone to the participant to explain the reason for the call: "I want to speak with you because I was diagnosed with HIV and I believe we shared an exposure." Alternately, participants who wish to notify partners in person are coached to inform partners that they have a serious health matter that they wish to discuss, and ask the partner to visit them in jail/prison. Either way, the APN counselor is present to record the names of partners whom participants self-notify, and offers to speak with the partner immediately afterwards to answer their questions about HIV and to provide information about HIV testing and contact information should the partner wish to contact an HIV provider on their own to learn more about HIV testing or to schedule an HIV test.

Impart Choice of APN or Self-Tell Per PartnerSelf-Tell Notification Only Standard of Care Condition

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV-diagnosed
  • Sexually active (penile-vaginal or penile-anal) and/or sharing injection equipment during the year before incarceration

You may not qualify if:

  • Incarcerated more than 5 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fakultas Ilmu Keperawatan, Universitas Indonesia

Depok, West Java, 16424, Indonesia

Location

Related Publications (2)

  • Culbert GJ, Levy JA, Steffen AD, Waluyo A, Earnshaw VA, Rahadi A. Impart: findings from a prison-based model of HIV assisted partner notification in Indonesia. J Int AIDS Soc. 2023 Jun;26(6):e26132. doi: 10.1002/jia2.26132.

    PMID: 37339342BACKGROUND
  • Culbert GJ, Waluyo A, Levy JA, Steffen AD, Earnshaw VA, Rahadi A. Prison-based HIV partner notification in Indonesia: rationale and design of a hybrid type 1 effectiveness-implementation study. BMC Public Health. 2026 Mar 16;26(1):1321. doi: 10.1186/s12889-026-26950-z.

MeSH Terms

Conditions

Sexually Transmitted Diseases

Condition Hierarchy (Ancestors)

Communicable DiseasesInfectionsGenital DiseasesUrogenital DiseasesDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Agung Waluyo, PhD

    Indonesia University

    PRINCIPAL INVESTIGATOR
  • Gabriel Culbert, PhD

    University of Illinois at Chicago

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gabriel Culbert, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Statistician
Purpose
SCREENING
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2025

First Posted

August 5, 2025

Study Start

June 1, 2026

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

July 9, 2026

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

All data collected for this study will follow the NIH Policy for Data Management and Sharing (NOT-OD-21-013) and NIMH's extensions that apply to HIV-related applications that involve human subject research funded by NIMH. Raw and analyzed data from this study will be deposited into the NIMH Data Archive (NDA). Other data outputs also will be housed in the University of Illinois Chicago institutional repository, INDIGO, which is able to store non-sensitive information.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
We will share data with the research community when papers using the data have been accepted for publication or at the end of the award period, whichever occurs sooner.
Access Criteria
Access to de-identified scientific data will not be restricted. Due to the sensitive nature of the topic, identifiable data will be limited to sharing through data use agreements.

Locations